Clinical Trial: Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test
Brief Summary:
The study will determine the performance of the Infinium HD Test.
- The primary objective of the study is to assess the performance of the Infinium HD Test using banked DNA samples extracted from whole blood patient samples derived from the intended use population.
- The secondary objective of the study is to determine the background number of chromosomal abnormalities per person in the general population based on the resolution of the Infinium HD Test.
Detailed Summary:
Sponsor: Illumina, Inc.
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Illumina, Inc.
Dates:
Date Received: August 29, 2011
Date Started: August 2011
Date Completion:
Last Updated: April 26, 2016
Last Verified: September 2011
